Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference
Xeris Biopharma Holdings (Nasdaq: XERS) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's senior management will engage in a fireside chat scheduled for December 3, 2024, at 8:00am Eastern Time. The event will be accessible through a live webcast on the 'Events & Presentations' section of Xeris' Investor Relations website, with a replay available for 30 days following the presentation.
Xeris Biopharma Holdings (Nasdaq: XERS) ha annunciato la sua partecipazione alla 36a Conferenza Annuale sulla Salute di Piper Sandler. La gestione senior dell'azienda parteciperà a un incontro colloquiale previsto per il 3 dicembre 2024, alle 8:00 ora orientale. L'evento sarà accessibile tramite una diretta web nella sezione 'Eventi e Presentazioni' del sito Relazioni con gli Investitori di Xeris, con una registrazione disponibile per 30 giorni dopo la presentazione.
Xeris Biopharma Holdings (Nasdaq: XERS) ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. La alta dirección de la compañía se involucrará en una charla programada para el 3 de diciembre de 2024, a las 8:00 a.m. hora del Este. El evento será accesible a través de una transmisión en vivo en la sección 'Eventos y Presentaciones' del sitio web de Relaciones con Inversores de Xeris, con una repetición disponible por 30 días después de la presentación.
Xeris Biopharma Holdings (Nasdaq: XERS)는 Piper Sandler 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 고위 관리진은 2024년 12월 3일 오전 8시(동부 표준시)에 예정된 담소에 참여할 것입니다. 이 행사는 Xeris 투자자 관계 웹사이트의 '이벤트 및 프레젠테이션' 섹션을 통해 실시간 웹캐스트로 접속할 수 있으며, 발표 후 30일 동안 재생이 가능합니다.
Xeris Biopharma Holdings (Nasdaq: XERS) a annoncé sa participation à la 36e Conférence Annuelle sur les Soins de Santé de Piper Sandler. La direction senior de l'entreprise participera à une discussion informelle prévue pour le 3 décembre 2024, à 8h00, heure de l'Est. L'événement sera accessible via un webinaire en direct dans la section 'Événements et Présentations' du site Web des Relations avec les Investisseurs de Xeris, avec un replay disponible pendant 30 jours après la présentation.
Xeris Biopharma Holdings (Nasdaq: XERS) hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler bekannt gegeben. Das obere Management des Unternehmens wird an einem geplanten Fireside Chat am 3. Dezember 2024 um 8:00 Uhr Eastern Time teilnehmen. Die Veranstaltung wird über einen Live-Webcast im Abschnitt 'Veranstaltungen & Präsentationen' der Investor Relations-Website von Xeris zugänglich sein, mit einer Wiederholung, die 30 Tage nach der Präsentation verfügbar ist.
- None.
- None.
A live webcast of the event will be available on the 'Events & Presentations' section of Xeris’ Investor Relations website at www.xerispharma.com. A replay of the webcast will be available for 30 days.
About Xeris
Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products: Recorlev®, for the treatment of endogenous Cushing’s syndrome; Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis®, a proven therapy for primary periodic paralysis. Xeris also has a pipeline of development programs to bring new products forward using its proprietary formulation technology platforms, XeriSol® and XeriJect®, supporting long-term product development and commercial success.
Xeris Biopharma Holdings is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241125772487/en/
Investor Contact
Allison Wey
Senior Vice President, Investor Relations and Corporate Communications
awey@xerispharma.com
Source: Xeris Biopharma
FAQ
When is Xeris Biopharma (XERS) presenting at the Piper Sandler Healthcare Conference?
How can investors watch Xeris Biopharma's (XERS) presentation at the Piper Sandler Conference?
How long will the replay of Xeris Biopharma's (XERS) Piper Sandler Conference presentation be available?
What type of presentation will Xeris Biopharma (XERS) give at the Piper Sandler Conference?
